Authors: Wujin Sun, Jinqiang Wang, Quanyin Hu, Xingwu Zhou, Ali Khademhosseini, Zhen Gu
Published: 2020-05-20
DOI: 10.1126/sciadv.aba2983
Source: Full article
A DNA-based bioresponsive nanoformulation delivers the CRISPR-Cas12a to hepatocytes for regulating serum cholesterol.